OneMedNet (ONMD) EBIT (2021 - 2026)

OneMedNet (ONMD) has reported EBIT for 6 consecutive years, with -$2.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT fell 9.6% year-over-year to -$2.3 million in Q2 2026; TTM through Jun 2026 was -$10.1 million, a 8.47% decrease from a year earlier, with the FY2025 full-year figure at -$9.7 million, down 0.65% from the prior year.
• EBIT was -$2.3 million for Q2 2026 at OneMedNet, up from -$2.6 million in the prior quarter.
• Over five years, EBIT peaked at -$520025.0 in Q3 2022 and troughed at -$5.8 million in Q4 2022.
• A 5-year average of -$2.1 million and a median of -$2.2 million in 2024 frame the typical range for EBIT.
• Across the five-year window, EBIT sank 72111.24% in 2022 and soared 67.74% in 2023, its largest moves.
• Over 5 years, EBIT stood at -$5.8 million in 2022, then soared by 67.74% to -$1.9 million in 2023, then sank by 45.4% to -$2.7 million in 2024, then retreated by 13.48% to -$3.1 million in 2025, then gained by 26.64% to -$2.3 million in 2026.
• The last three EBIT figures came in at -$2.3 million (Q2 2026), -$2.6 million (Q1 2026), and -$3.1 million (Q4 2025), per Business Quant data.